Volume 26, Issue 2, Pages (February 2007)

Slides:



Advertisements
Similar presentations
A novel SHP-1/Grb2–dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling.
Advertisements

Volume 9, Issue 5, Pages (November 1998)
Large Hepatitis Delta Antigen Modulates Transforming Growth Factor-β Signaling Cascades: Implication of Hepatitis Delta Virus–Induced Liver Fibrosis 
Differentiation of CD4+ T Cells to Th1 Cells Requires MAP Kinase JNK2
Volume 11, Issue 4, Pages (April 2003)
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
Volume 26, Issue 3, Pages (March 2007)
Volume 25, Issue 6, Pages (December 2006)
Inhibition of Th1 Differentiation by IL-6 Is Mediated by SOCS1
by Katriina J. Peltola, Kirsi Paukku, Teija L. T
Volume 31, Issue 2, Pages (August 2009)
Shitao Li, Lingyan Wang, Michael A. Berman, Ye Zhang, Martin E. Dorf 
Volume 24, Issue 5, Pages (May 2006)
Volume 23, Issue 6, Pages (December 2005)
Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor α expression by inducing.
Volume 87, Issue 7, Pages (December 1996)
Volume 46, Issue 2, Pages (February 2017)
ROG, Repressor of GATA, Regulates the Expression of Cytokine Genes
Volume 15, Issue 1, Pages (July 2001)
Volume 30, Issue 3, Pages (March 2009)
Volume 26, Issue 1, Pages (January 2007)
Arginine Methylation of STAT1 Modulates IFNα/β-Induced Transcription
Yongli Bai, Chun Yang, Kathrin Hu, Chris Elly, Yun-Cai Liu 
Mark H Kaplan, Ulrike Schindler, Stephen T Smiley, Michael J Grusby 
Jürgen Ruland, Gordon S Duncan, Andrew Wakeham, Tak W Mak  Immunity 
James I Kim, I-Cheng Ho, Michael J Grusby, Laurie H Glimcher  Immunity 
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
Volume 29, Issue 4, Pages (October 2008)
Volume 37, Issue 4, Pages (October 2012)
Mechanisms of cross hyporesponsiveness to toll-like receptor bacterial ligands in intestinal epithelial cells  Jan-Michel Otte, Elke Cario, Daniel K.
Volume 34, Issue 1, Pages (January 2011)
MyD88: An Adapter That Recruits IRAK to the IL-1 Receptor Complex
Volume 115, Issue 5, Pages (November 2003)
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
Histamine Inhibits the Production of Interferon-induced Protein of 10 kDa in Human Squamous Cell Carcinoma and Melanoma  Naoko Kanda, Shinichi Watanabe 
Naoko Kanda, Shinichi Watanabe  Journal of Investigative Dermatology 
Volume 33, Issue 3, Pages (September 2010)
Volume 4, Issue 4, Pages (April 1996)
Volume 28, Issue 4, Pages (April 2008)
Lysine 63 Polyubiquitination of the Nerve Growth Factor Receptor TrkA Directs Internalization and Signaling  Thangiah Geetha, Jianxiong Jiang, Marie W.
c-Src Activates Endonuclease-Mediated mRNA Decay
ROG, Repressor of GATA, Regulates the Expression of Cytokine Genes
Volume 15, Issue 4, Pages (August 2004)
Volume 9, Issue 5, Pages (November 1998)
Cell Type-Specific Involvement of RIG-I in Antiviral Response
Volume 36, Issue 4, Pages (April 2012)
Volume 21, Issue 6, Pages (November 2017)
Volume 10, Issue 4, Pages (April 1999)
Volume 31, Issue 6, Pages (December 2009)
Volume 43, Issue 4, Pages (October 2015)
Silva H Hanissian, Raif S Geha  Immunity 
Volume 32, Issue 2, Pages (February 2010)
Yap1 Phosphorylation by c-Abl Is a Critical Step in Selective Activation of Proapoptotic Genes in Response to DNA Damage  Dan Levy, Yaarit Adamovich,
Volume 125, Issue 4, Pages (May 2006)
IFN-γ Represses IL-4 Expression via IRF-1 and IRF-2
Volume 33, Issue 5, Pages (November 2010)
Volume 33, Issue 1, Pages (July 2010)
Volume 35, Issue 4, Pages (October 2011)
Naoko Kanda, Shinichi Watanabe  Journal of Investigative Dermatology 
Volume 27, Issue 4, Pages (October 2007)
Volume 31, Issue 6, Pages (December 2009)
Volume 9, Issue 5, Pages (November 1998)
Heterozygous N-terminal deletion of IκBα results in functional nuclear factor κB haploinsufficiency, ectodermal dysplasia, and immune deficiency  Douglas.
PU.1 Expression Delineates Heterogeneity in Primary Th2 Cells
Phosphorylation of CBP by IKKα Promotes Cell Growth by Switching the Binding Preference of CBP from p53 to NF-κB  Wei-Chien Huang, Tsai-Kai Ju, Mien-Chie.
Volume 15, Issue 4, Pages (April 2009)
Volume 129, Issue 5, Pages (June 2007)
Volume 12, Issue 6, Pages (March 2002)
Volume 38, Issue 3, Pages (March 2013)
Volume 31, Issue 5, Pages (September 2008)
Presentation transcript:

Volume 26, Issue 2, Pages 163-176 (February 2007) Regulation of Signal Transducer and Activator of Transcription Signaling by the Tyrosine Phosphatase PTP-BL  Masakiyo Nakahira, Takashi Tanaka, Bryanne E. Robson, Joseph P. Mizgerd, Michael J. Grusby  Immunity  Volume 26, Issue 2, Pages 163-176 (February 2007) DOI: 10.1016/j.immuni.2007.01.010 Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 1 PTP-BL Interacts with STAT4 (A) Schematic diagram of the leucine zipper motif of STAT4 used as bait in a yeast two-hybrid screen for STAT-interacting proteins. (B) PTP-BL interacts with STAT4 independent of tyrosine phosphorylation. Expression vectors for FLAG-tagged STAT4 wild-type (WT) or Y693F mutant (1.0 μg each) were cotransfected into 293T cells together with those for c-Myc-tagged PTP-BL frame-shift (FS) or C2285S (CS) mutants (11 μg each) as indicated. Total cell lysates prepared from the transfected cells stimulated with IFN-α (1000 U/ml) for 30 min, or left unstimulated, were immunoprecipitated (IP) with anti-c-Myc and subjected to immunoblot with anti-STAT4. Data are representative of three independent experiments. Immunity 2007 26, 163-176DOI: (10.1016/j.immuni.2007.01.010) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 2 PTP-BL Dephosphorylates STAT4 through Its PTPase Domain (A) PTP-BL impairs STAT4 phosphorylation. An expression vector for FLAG-tagged STAT4 (0.6 μg) was cotransfected into 293T cells together with those for c-Myc-tagged PTP-BL (FS, WT, or ΔC) (12 μg each). Total cell lysates from cells treated with IFN-α (1000 U/ml) for 30 min were immunoprecipitated with anti-FLAG and immunobloted with anti-phospho STAT4. Data are representative of three independent experiments. (B) PTP-BL inhibits STAT4-mediated transactivation. An IRF-1 luciferase reporter construct (0.2 μg) and an expression vector for FLAG-tagged STAT4 (0.2 μg) were cotransfected into 293T cells together with those for c-Myc-tagged PTP-BL (FS, WT, or ΔC) (2.0 μg each). Cells were stimulated with IFN-α (1000 U/ml) for 6 hr and cell lysates were subjected to luciferase assay. Data are representative of three independent experiments. (C) Purification of GST-tagged PTPase domain of PTP-BL. HighFive insect cells were infected with recombinant baculovirus that encodes either glutathoine S-transferase (GST) or GST-tagged PTPase domain of PTP-BL for 40 hr. GST-tagged proteins were prepared by affinity purification and visualized by coomassie staining. (D) PTP-BL can directly dephosphorylate STAT4. Phosphorylated STAT4 was immunoprecipitated with anti-FLAG from IFN-α-stimulated 293T transfectants and incubated with 0.2 μg/μl recombinant proteins. Immunoprecipitates were subjected to immunoblot with anti-phospho-tyrosine (PY20). Equal loading was verified by reprobing with anti-STAT4. Data are representative of three independent experiments. Immunity 2007 26, 163-176DOI: (10.1016/j.immuni.2007.01.010) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 3 PTP-BL Inhibits IL-12 Signaling at the Level of STAT4 Phosphorylation (A) Overexpression of PTP-BL in 2D6 cells. (B) The pattern of tyrosine phosphorylated proteins in 2D6 cells overexpressing PTP-BL. (C) PTP-BL impairs IL-12-induced STAT4 phosphorylation. IL-12-starved 2D6 cell transfectants expressing c-Myc-PTP-BL (FS or WT) were stimulated with IL-12 (1 ng/ml) for the indicated times. Total cell lysates were immunoblotted with anti-phospho STAT4. Data are representative of three independent experiments. (D) PTP-BL does not impair IL-12-induced Tyk2 phosphorylation. IL-12-starved 2D6 transfectants were stimulated with IL-12 (1 ng/ml) for 15 min. Total cell lysates were immunoblotted with anti-phospho Tyk2. Data are representative of three independent experiments. (E) PTP-BL overexpression impairs IL-12-induced IFN-γ production. IL-12-starved 2D6 cell clones (2 × 105 cells/well) were cultured without or with IL-12 (5 ng/ml) or PMA (50 ng/ml) plus ionomycin (1 μg/ml) in 96-well culture plates. After 24 hr, supernatants were harvested and IFN-γ production was measured by ELISA. Data are presented as mean ± SD of triplicate samples. Immunity 2007 26, 163-176DOI: (10.1016/j.immuni.2007.01.010) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 4 PTP-BL Dephosphorylates Multiple STAT Family Members (A) PTP-BL impairs STAT6 phosphorylation. An expression vector for FLAG-tagged STAT6 (0.6 μg) was cotransfected into 293T cells together with those for c-Myc-tagged PTP-BL (FS, WT, or ΔC) (12 μg each). Total cell lysates from cells treated with IL-4 (10 ng/ml) for 30 min were immunoprecipitated with anti-FLAG and subjected to immunoblot with anti-phospho STAT6. Data are representative of three independent experiments. (B) PTP-BL inhibits STAT6-mediated transactivation. A STAT6-responsive luciferase reporter construct (TPU474) (0.2 μg), and a STAT6 expression vector (0.2 μg) were cotransfected into 293T cells together with increasing amounts (0.25, 0.5, 1.0, and 2.0 μg) of c-Myc-tagged PTP-BL expression vectors (WT or ΔC). The total amount of transfected PTP-BL vector in each sample was adjusted to 2.0 μg by the addition of PTP-BL (FS). 24 hr after transfection, cells were stimulated with IL-4 (10 ng/ml) for 6 hr and lysates were subjected to luciferase assay. Data are representative of two independent experiments. (C) PTP-BL can dephosphorylate STAT6 in vitro. Phosphorylated STAT6 was immunoprecipitated with anti-FLAG from IL-4-stimulated 293T transfectants and incubated with 0.25 μg/μl recombinant proteins. Immunoprecipitates were probed with anti-phospho tyrosine (PY20). Equal loading was verified by reprobing with anti-STAT6. Data are representative of two independent experiments. (D) PTP-BL does not inhibit NF-κB-mediated transactivation. A luciferase reporter construct that contains five copies of NF-κB binding sequence (0.2 μg) and an NF-κB p65 expression vector (0.2 μg) were cotransfected into 293T cells together with c-Myc-tagged PTP-BL expression vectors (WT or ΔC). The total amount of transfected PTP-BL vector in each sample was adjusted to 2.0 μg by the addition of PTP-BL (FS). 30 hr after transfection, cells were harvested and lysates were subjected to luciferase assay. Data are representative of two independent experiments. Immunity 2007 26, 163-176DOI: (10.1016/j.immuni.2007.01.010) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 5 Generation of PTP-BL-Deficient Mice and PTP-BL Expression in CD4+ T Cells (A) Gene targeting construct for disruption of Ptpn13. Restriction enzymes are the following: Ec, EcoRI; Xb, XbaI; Xh, XhoI. (B) Southern blot analysis of tail DNA from wild-type (+/+), heterozygous (+/−), and PTP-BL-deficient (−/−) mice. (C) Northern blot analysis of total RNA isolated from the kidneys of wild-type or PTP-BL-deficient mice. 18S and 28S RNAs are shown to verify equal loading in each lane. (D) PTP-BL expression in CD4+ T cells from wild-type and PTP-BL-deficient mice. Total cell lysates were prepared from freshly isolated CD4+ T cells and subjected to immunoblot with anti-PTP-BL. (E) Subcellular localization of PTP-BL. CD4+ T cells from wild-type and PTP-BL-deficient mice were differentiated under Th1 or Th2 cell conditions for 5 days. Cytoplasmic and nuclear extracts were prepared and analyzed by immunoblot with anti-PTP-BL. Immunity 2007 26, 163-176DOI: (10.1016/j.immuni.2007.01.010) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 6 STAT Activation Is Increased and Prolonged in PTP-BL-Deficient CD4+ T Cells (A) STAT4 phosphorylation is increased in PTP-BL-deficient CD4+ T cells. Freshly isolated CD4+ T cells were stimulated with immobilized anti-CD3 (1 μg/ml for coating), 1 μg/ml anti-CD28, 100 U/ml human IL-2, 5 ng/ml murine IL-12, and 10 μg/ml anti-IL-4 for 15 hr. Cytoplasmic and nuclear extracts were subjected to immunoblot as indicated. Data are representative of three independent experiments. (B) STAT4 phosphorylation is prolonged in PTP-BL-deficient CD4+ T cells. Freshly isolated CD4+ T cells were stimulated with IFN-α (3000 U/ml) for 30 min, followed by staurosporine chase (0.5 μM) for another 15, 30, or 45 min. Cytoplasmic and nuclear extracts were subjected to immunoblot as indicated. Data are representative of three independent experiments. (C) Prolonged STAT6 DNA binding activity in nuclei of PTP-BL-deficient CD4+ T cells. Freshly isolated WT and PTP-BL-deficient CD4+ T cells were stimulated with IL-4 (40 ng/ml) for 30 min, followed by staurosporine chase (0.5 μM) for another 15 or 30 min. Nuclear extracts (1.3 μg) were subjected to EMSA with STAT6 and Sp1 consensus probes. Data are representative of two independent experiments. Immunity 2007 26, 163-176DOI: (10.1016/j.immuni.2007.01.010) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 7 Enhanced Th1 and Th2 Cell Differentiation in PTP-BL-Deficient CD4+ T Cells (A) Increased IFN-γ and IL-4 production by PTP-BL-deficient Th and Th2 cells after secondary stimulation. CD4+ T cells isolated from WT and PTP-BL-deficient mice were differentiated under unskewed (UNSK), Th1-, and Th2-skewing conditions for 5 days and then restimulated with plate-bound anti-CD3. IFN-γ and IL-4 production was measured by ELISA. Data are presented as mean ± SD of triplicate samples and are representative of four independent experiments. (B) Enhanced Th1 and Th2 cell differentiation in PTP-BL-deficient CD4+ T cells. The generation of Th1 and Th2 cells was assessed by intracellular cytokine staining. The percentages of cells in each quadrant are shown. Data are representative of three independent experiments. (C) Enhanced pulmonary bacterial clearance in PTP-BL-deficient mice. 48 hr after intratracheal K. pneumoniae infection (7 mice per each group), CFU/ml lung homogenate were assessed in WT and PTP-BL-deficient mice. Data are presented as mean ± SEM. Immunity 2007 26, 163-176DOI: (10.1016/j.immuni.2007.01.010) Copyright © 2007 Elsevier Inc. Terms and Conditions